06/13/2026
After much thought and re-wording. Here is my public post : “I am compelled to address a pressing concern regarding Alpha-Gal Syndrome (AGS) and the associated insurance implications. As the mother of a child diagnosed with AGS, I have been advocating for label changes since last October, driven by the alarming number of cases in our rural community. In our community of 2500, we personally know over 50 individuals who have tested positive. I would like to acknowledge the tireless efforts of Missouri House Representative Matthew Overcast, who has been instrumental in championing the AGS cause. However, our work remains unfinished.
Recently, I was hospitalized with severe symptoms, and after numerous tests, I was diagnosed with AGS. Despite my primary care provider's recommendation for an EpiPen prescription, my insurance company denied the request, citing 'not meeting criteria.' Their policy limits coverage to four EpiPens, after which there is no further support. This raises critical questions: How can insurance companies dictate whose life is worth saving? What legal framework permits them to deny coverage for life-saving medication for a top 10 listed allergy? How can Insurance Companies predetermine the value of a life by imposing a limit on essential treatment?
MiMissoMissouri Attorney General's OfficeKTed Kennedy Jr.oMissouri Lawyers MedialDonald J. TrumpaJD Vanceou able to help me understand, better?
